How to Upgrade the Human-Tech Interface? FIIPRIORITY

Irene Hong is the founding partner of CEC Capital Group, a leading investment bank in China focusing on technology, consumer, and healthcare. She specializes in healthcare investments. Dr. Li Pinglu is the founder and CEO of High Tide Therapeutics, a pharmaceutical company working on drugs for metabolic diseases like obesity and diabetes. Ivana Salhuddin is the founder of Symedra, a company testing for cancer and developing dietary supplements using AI. The discussion focused on biotech advancements in diagnostics, therapeutics, and drug discovery with a holistic patient approach. Using AI for data analysis was highlighted as a crucial tool, but its limitations due to data quality were acknowledged. The panelists emphasized personalized medicine, longevity with quality of life, and making biotech more affordable and accessible. The future of biotech and healthcare remains unpredictable due to rapid technological advancements and regulatory challenges, raising questions about extending healthy lifespans and the implications of AI on consciousness.